SPOK
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Ref P/E, PEG, Graham Number
- Moderate P/E of 15.33
- Price exceeds Graham Number ($10.95)
- Price is 119% above Intrinsic Value ($5.25)
Ref Growth rates
- Revenue growth is flat (-0.10%)
- Earnings growth is sharply negative (-27.2%)
Ref Historical trends
- Positive 5Y change (+73.7%)
- Poor 1Y performance (-19.9%)
- Recent 6M decline (-23.7%)
Ref Altman Z-Score, Piotroski F-Score
- Very low leverage (Debt/Equity 0.05)
- Positive ROE (10.55%)
- Piotroski F-Score is only 4/9 (Stable, not Strong)
Ref Yield, Payout
- High nominal yield (10.88%)
- Payout ratio of 166.67% indicates imminent risk of dividend cut
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for SPOK and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
SPOK
Spok Holdings, Inc.
Primary
|
+73.7% | +21.1% | -19.9% | -23.7% | +2.4% | +3.5% |
|
SLGL
Sol-Gel Technologies Ltd.
Peer
|
-48.3% | +88.0% | +1243.1% | +82.0% | -1.9% | -1.3% |
|
PROF
Profound Medical Corp.
Peer
|
-66.8% | -41.5% | +39.1% | +20.2% | +21.6% | +11.8% |
|
CAMP
CAMP4 THERAPEUTICS CORPORATION
Peer
|
-56.6% | -56.6% | +78.8% | +41.3% | -25.9% | +5.4% |
|
ALEC
Alector, Inc.
Peer
|
-88.2% | -66.9% | +53.9% | -20.0% | +14.6% | +10.0% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
SPOK
Spok Holdings, Inc.
|
BEARISH | $238.4M | 15.33 | 10.5% | 11.4% | $11.5 | |
|
SLGL
Sol-Gel Technologies Ltd.
|
BEARISH | $239.73M | - | -23.7% | -31.6% | $73.87 | Compare |
|
PROF
Profound Medical Corp.
|
BEARISH | $241.35M | - | -67.1% | -264.4% | $6.65 | Compare |
|
CAMP
CAMP4 THERAPEUTICS CORPORATION
|
BEARISH | $241.42M | - | -145.1% | -% | $4.65 | Compare |
|
ALEC
Alector, Inc.
|
BEARISH | $242.8M | - | -181.6% | -% | $2.2 | Compare |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-14 | RICE CALVIN | Chief Financial Officer | Stock Award | 21,359 | - |
| 2026-04-01 | STEIN TODD J. | Director | Stock Award | 2,294 | $25,005 |
| 2026-04-01 | BYRNE BARBARA PETERSON | Director | Stock Award | 2,294 | $25,005 |
| 2026-04-01 | SHOCKLEY BRETT A | Director | Stock Award | 2,294 | $25,005 |
| 2026-04-01 | HYUN RANDY | Director | Stock Award | 2,294 | $25,005 |
| 2026-04-01 | COURNOYER CHRISTINE M | Director | Stock Award | 2,294 | $25,005 |
| 2026-03-04 | RICE CALVIN | Chief Financial Officer | Stock Award | 4,120 | $50,017 |
| 2026-03-04 | RICE CALVIN | Chief Financial Officer | Stock Award | 13,736 | - |
| 2026-03-04 | KELLY VINCENT D | Chief Executive Officer | Stock Award | 14,652 | $177,875 |
| 2026-03-04 | KELLY VINCENT D | Chief Executive Officer | Option Exercise | 48,840 | $592,918 |
| 2026-03-04 | WALLACE MICHAEL W. | Chief Operating Officer | Stock Award | 9,157 | $111,166 |
| 2026-03-04 | WALLACE MICHAEL W. | Chief Operating Officer | Option Exercise | 30,525 | $370,574 |
| 2026-03-04 | WOODS-KEISLING SHARON | Officer and Treasurer | Stock Award | 3,434 | $41,689 |
| 2026-03-04 | WOODS-KEISLING SHARON | Officer and Treasurer | Stock Award | 11,447 | - |
| 2026-01-05 | RICE CALVIN | Chief Financial Officer | Option Exercise | 11,452 | $151,052 |
SEC Filings
Recent regulatory filings from the SEC EDGAR database
SPOK Holdings, Inc. generates revenue through a combination of perpetual and term software licenses, hardware sales, professional services, and maintenance and subscription contracts typically spanning one to three years. Revenue is recognized upon the transfer of control of promised goods or services to customers. Specific financial performance metrics and detailed risk factors were not provided in the available excerpts.
SPOK Holdings, Inc. generates revenue through a combination of perpetual and term software licenses, hardware sales, professional services, and recurring maintenance and subscription fees. Revenue is recognized upon the transfer of control of the promised goods or services to the customer. Detailed risk factors are disclosed under Item 1A of the filing.
Wall Street Analysts
Professional analyst ratings and price targets
Past News Coverage
Recent headlines mentioning SPOK from our newsroom.